Previous research links type 2 diabetes and metabolic dysfunction–associated steatotic liver disease (MASLD). Children with uncontrolled type 1 diabetes (T1D) appear to face an increased risk of ...

Glycemic control improved with increased diabetes technology use, yet overall control remains low among T1D patients in the US. Significant disparities in glycemic control and technology use persist ...

Glycogenic hepatopathy is a recognised but underappreciated complication in individuals with type 1 diabetes mellitus, marked by the excessive accumulation of glycogen in hepatocytes. Clinically, ...

The oral Janus kinase inhibitor baricitinib (Olumiant) preserved beta-cell function in people with new-onset type 1 diabetes over 48 weeks, new phase 2 data show. A randomized, placebo-controlled ...

Identifying children with early signs of type 1 diabetes makes a difference to their health. A new study suggests wider ...

Recent clinical trials have shown promising results of transplanting these cells into individuals with Type 1 diabetes: ...

Explore the potential benefits and risks of using type 2 diabetes drugs like Ozempic and metformin off-label to manage weight ...

Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...

Toujeo is an injectable insulin medication for the treatment of diabetes (type 1 or type 2) in people who are 6 years old and older. It is a long-acting form of insulin, which allows it to last for a ...